Henry Klar Yaggi

Henry Klar Yaggi

Auto-generated profile, based on publicly available information

Henry Klar Yaggi

Department of Medicine, Yale University School of Medicine, New Haven, CT 06510, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
HYH. Klar Yaggi
H. Klar Yaggi
AAAndre B. Araujo
Andre B. Araujo
JMJohn B. McKinlay
John B. McKinlay
OBJECTIVE—Short-term partial sleep restriction results in glucose intolerance and insulin resistance. The purpose of this study was to assess the long-term relationship between sleep duration and the incidence of clinical diabetes. RESEARCH DESIGN AND METHODS—A cohort of men from the Massachusetts Male Aging Study without diabetes at baseline (1987–1989) were followed until 2004 for the development of diabetes. Average number of hours of sleep per night was grouped into the following categories: ≤5, 6, 7, 8, and >8 h. Incidence rates and relative risks (RRs) were calculated for the development of diabetes in each sleep duration category. Those reporting 7 h of sleep per night served as the reference group. Multivariate analysis was performed using Poisson regression. RESULTS—Men reporting short sleep duration (≤5 and 6 h of sleep per night) were twice as likely to develop diabetes, and men reporting long sleep duration (>8 h of sleep per night) were more than three times as likely to develop diabetes over the period of follow-up. Elevated risks remained essentially unchanged after adjustment for age, hypertension, smoking status, self-rated health status, education, and waist circumference (RR 1.95 [95% CI 0.95–4.01] for ≤5 h and 3.12 [1.53–6.37] for >8 h). RRs were altered considerably for the two extreme sleep groups when adjusted for testosterone (1.51 [0.71–3.19] for ≤5 h and 2.81 [1.34–5.90] for >8 h), suggesting that the effects of sleep on diabetes could be mediated via changes in endogenous testosterone levels. CONCLUSIONS—Short and long sleep durations increase the risk of developing diabetes, independent of confounding factors. Sleep duration may represent a novel risk factor for diabetes.

24 September 2009 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
NSNeomi A. Shah
Neomi A. Shah
HYHenry Klar Yaggi
Henry Klar Yaggi
JCJohn Concato
John Concato
VMVahid Mohsenin
Vahid Mohsenin

21 September 2017 in Thorax
Verified
Journal Article
Open access
PDF file
AZAndrey Zinchuk
Andrey Zinchuk
SJSangchoon Jeon
Sangchoon Jeon
BKBrian B Koo
Brian B Koo
XYXiting Yan
Xiting Yan
DBDawn M Bravata
Dawn M Bravata
HYHenry K Yaggi
Henry K Yaggi
Background Obstructive sleep apnoea (OSA) is a heterogeneous disorder, and improved understanding of physiologic phenotypes and their clinical implications is needed. We aimed to determine whether routine polysomnographic data can be used to identify OSA phenotypes (clusters) and to assess the associations between the phenotypes and cardiovascular outcomes. Methods Cross-sectional and longitudinal analyses of a multisite, observational US Veteran (n=1247) cohort were performed. Principal components-based clustering was used to identify polysomnographic features in OSA’s four pathophysiological domains (sleep architecture disturbance, autonomic dysregulation, breathing disturbance and hypoxia). Using these features, OSA phenotypes were identified by cluster analysis (K-means). Cox survival analysis was used to evaluate longitudinal relationships between clusters and the combined outcome of incident transient ischaemic attack, stroke, acute coronary syndrome or death. Results Seven patient clusters were identified based on distinguishing polysomnographic features: ‘mild’, ‘periodic limb movements of sleep (PLMS)’, ‘NREM and arousal’, ‘REM and hypoxia’, ‘hypopnoea and hypoxia’, ‘arousal and poor sleep’ and ‘combined severe’. In adjusted analyses, the risk (compared with ‘mild’) of the combined outcome (HR (95% CI)) was significantly increased for ‘PLMS’, (2.02 (1.32 to 3.08)), ‘hypopnoea and hypoxia’ (1.74 (1.02 to 2.99)) and ‘combined severe’ (1.69 (1.09 to 2.62)). Conventional apnoea–hypopnoea index (AHI) severity categories of moderate (15≤AHI<30) and severe (AHI ≥30), compared with mild/none category (AHI <15), were not associated with increased risk. Conclusions Among patients referred for OSA evaluation, routine polysomnographic data can identify physiological phenotypes that capture risk of adverse cardiovascular outcomes otherwise missed by conventional OSA severity classification.

1 June 2010 in Clinics in Chest Medicine
Verified
Journal Article
Closed access
HYH. Klar Yaggi
H. Klar Yaggi
KSKingman P. Strohl
Kingman P. Strohl

1 September 2014 in Heart & Lung
Verified
Journal Article
Closed access
MKMelissa P. Knauert
Melissa P. Knauert
HYH. Klar Yaggi
H. Klar Yaggi
NRNancy S. Redeker
Nancy S. Redeker
TMTerrence E. E. Murphy
Terrence E. E. Murphy
KAKaty L. Araujo
Katy L. Araujo
MPMargaret A. Pisani
Margaret A. Pisani

15 June 2016 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
BSBernardo J. Selim
Bernardo J. Selim
BKBrian B. Koo
Brian B. Koo
LQLi Qin
Li Qin
SJSangchoon Jeon
Sangchoon Jeon
CWChristine Won
Christine Won
HYHenry K. Yaggi
Henry K. Yaggi
To determine whether sleep-disordered breathing (SDB) is associated with cardiac arrhythmia in a clinic-based population with multiple cardiovascular comorbidities and severe SDB. This was a cross-sectional analysis of 697 veterans who underwent polysomnography for suspected SDB. SDB was categorized according to the apnea-hypopnea index (AHI): none (AHI < 5), mild (5 ≥ AHI < 15), and moderate-severe (AHI ≥ 15). Nocturnal cardiac arrhythmias consisted of: (1) complex ventricular ectopy, (CVE: non-sustained ventricular tachycardia, bigeminy, trigeminy, or quadrigeminy), (2) combined supraventricular tachycardia, (CST: atrial fibrillation or supraventricular tachycardia), (3) intraventricular conduction delay (ICD), (4) tachyarrhythmias (ventricular and supraventricular), and (5) any cardiac arrhythmia. Unadjusted, adjusted logistic regression, and Cochran-Armitage testing examined the association between SDB and cardiac arrhythmias. Linear regression models explored the association between hypoxia, arousals, and cardiac arrhythmias. Compared to those without SDB, patients with moderate-severe SDB had almost three-fold unadjusted odds of any cardiac arrhythmia (2.94; CI 95%, 2.01–4.30; p < 0.0001), two-fold odds of tachyarrhythmias (2.16; CI 95%,1.47–3.18; p = 0.0011), two-fold odds of CVE (2.01; 1.36–2.96; p = 0.003), and two-fold odds of ICD (2.50; 1.58–3.95; p = 0.001). A linear trend was identified between SDB severity and all cardiac arrhythmia subtypes (p value linear trend < 0.0001). After adjusting for age, BMI, gender, and cardiovascular diseases, moderate-severe SDB patients had twice the odds of having nocturnal cardiac arrhythmias (2.24; 1.48–3.39; p = 0.004). Frequency of obstructive respiratory events and hypoxia were strong predictors of arrhythmia risk. SDB is independently associated with nocturnal cardiac arrhythmias. Increasing severity of SDB was associated with an increasing risk for any cardiac arrhythmia. Selim BJ, Koo BB, Qin L, Jeon S, Won C, Redeker NS, Lampert RJ, Concato JP, Bravata DM, Ferguson J, Strohl K, Bennett A, Zinchuk A, Yaggi HK. The association between nocturnal cardiac arrhythmias and sleep-disordered breathing: the DREAM study. J Clin Sleep Med 2016;12(6):829–837.